Empowering Ultrasound Innovation for 25 Years
The Leader in Research Ultrasound – Our History
Formed in 2001 with a focused vision to disrupt the field of ultrasound research and development (R&D), Verasonics aimed to provide researchers and developers with the most advanced and flexible solutions, enabling development of groundbreaking new algorithms and products across a wide range of applications. The Company invented a proprietary, novel, software-based beamforming architecture and data acquisition system with superior signal fidelity. This system would be capable of leveraging ongoing increases in computing performance to advance ultrasound R&D.
In 2007, Verasonics’ initial efforts culminated with the commercialization of its inaugural system, V-1, followed by the Vantage® Research Ultrasound System in 2013, and now the Vantage NXT Research Ultrasound System in 2023. Verasonics Systems combined key developments, including real-time access to raw ultrasound data, high frame-rate plane wave imaging/Doppler, and the capability to generate long pulses for radiation force and focused ultrasound (FUS). The release of the Verasonics V-1 system triggered a dramatic increase in shear-wave elastography research. As a result, shear-wave elastography for evaluating tissue stiffness has become a mainstay tool on most clinical ultrasound systems.
Similarly, given the growing community interest in FUS research and the need for versatile tools, Verasonics developed a new configuration for high-intensity focused ultrasound (HIFU) in 2010. The ability to program custom FUS transmit sequences, while also allowing for the integration in the very same sequence of B-mode image guidance and custom imaging/processing for treatment monitoring, was and remains truly groundbreaking. Coupling the FUS capability with powerful proprietary software and tools, alongside a wide selection of third-party transducers has allowed Verasonics systems to become the preferred platform used for FUS R&D in areas ranging from thermal and mechanical ablation, blood-brain barrier opening, neuromodulation, drug delivery, immunotherapy, and many others.
The Vantage NXT continues this tradition with further advances in high-frequency imaging, volume imaging, and arbitrary waveform generation, in addition to expanding pioneering performance to other areas of ultrasound R&D, including non-destructive testing, geophysics, and fluid mechanics.
Our Technology
Verasonics continually adapts and advances its ultrasound technology and has built an extensive product portfolio to cover a wide range of applications across biomedical, materials science, earth sciences, and the physics of acoustics and ultrasonics. A key goal is to support ultrasound innovation with an open, programmable, and flexible product that combines a high-performance data acquisition system with a proprietary software suite.
Verasonics platforms allow innovation from concept to validation by a single developer and support conventional imaging modes while enabling researchers to explore and develop novel acquisition methods and image formation. The Company has become distinguished in academic, commercial, and start-up ultrasound environments.
Key Highlights:
Diverse customer base spanning the world’s leading academic institutions, research institutes, start-ups, and large multi-national corporations
Verasonics’ research ultrasound systems have been cited in thousands of scientific publications
Multiple commercial licensees, including several organizations that have released regulatory-approved devices
Intellectual property coverage includes several unique technologies with patent protection across all key territories
Co-founder, Chairman, and Chief Innovation Officer, Ronald E. Daigle, Ph.D., was awarded the 2018 IEEE UFFC Achievement Award – the highest IEEE society-wide award – for his significant contributions to the ultrasound research community
Our Mission
The mission of Verasonics is to empower ultrasound innovation across the biomedical, materials science, earth sciences, and the physics of acoustics and ultrasonics fields.
Our mission turns purpose into impact.
We develop and provide our core technology—performance, flexibility, and integration—to make a positive impact across three pillars of emphasis: education, research, and commercial focus. Together, they ensure our technology delivers lasting, real‑world value.
Our Global Locations & Distributors
Leadership
Ron E. Daigle
Ron has over 45 years’ experience in ultrasound research and development, including 5 years as Director of Research at ATL Ultrasound, where he developed new digital beamforming methods for high bandwidth array imaging and advanced digital Doppler color flow imaging. He then served 8 years as Director of Technology at Atlantis Diagnostics International, an ATL subsidiary charged with developing computer-based ultrasound systems. He is the author on 45 ultrasound publications and named as an inventor on 20 ultrasound patents.
Jon K. Daigle
Jon joined Verasonics in 2015. Before his appointment as President and CEO, he was responsible for strategy, commercial licensing, strategic alliances, and program management. Prior to Verasonics, Jon held various roles in corporate strategy and development, strategic marketing, and product management at Medtronic and Becton Dickinson & Co. Jon holds a BA in Business Administration from Washington State University, an MBA from Columbia Business School, and a Master of International Affairs from Columbia University’s School of International and Public Affairs.
Stacy Douthitt
Stacy is a senior marketing and sales leader with 30 years of demonstrated results in commercial strategy and global marketing for medical device and life science firms. Before Verasonics, she held leadership positions at several MedTech companies, ranging from start-ups to Fortune 500. Stacy is responsible for sales, customer success, product marketing & communications, as well as strategic marketing & alliances. She holds a B.A. in Marketing from the University of Washington and an M.B.A. from the University of Phoenix.
Ron E. Daigle
Co-founder, Chairman & Chief Innovation Officer
Jon K. Daigle
President & Chief Executive Officer
Stacy Douthitt
Chief Business Officer
Matt Stupfel
Matt has over 30 years’ experience in financial, operational & commercial leadership, with an efficient record of bringing companies from early-stage start-up to publicly listed global corporations. His accomplishments include raising over $100M+ in equity and debt financing and leading corporate M&A processes, including multiple successful acquisitions. Matt is an alumnus of Seattle University.
Alex Exposito
Alex has over 25 years of experience in the ultrasound industry, having worked with multinational companies and ultrasound startups. He has held various roles in clinical, sales, and sales leadership at ATL/Philips, Fujifilm SonoSite, and Supersonic Imagine, providing best-in-class ultrasound technology to healthcare institutions prior to joining Verasonics in 2022. Alex holds a bachelor’s degree in business administration specializing in healthcare services from Barry University. Prior to his commercial healthcare experience, he worked in a clinical setting as a diagnostic medical sonographer.
Mike Pierce
Michael has over 30 years of experience in ultrasound and medical device development, marketing, and field service. Before Verasonics, he served as Director of Marketing and Operations at Medstreaming and spent 13 years at Philips serving in a variety of positions – Connectivity Engineer, Professional Services Consultant, and Field Marketing Manager.
Matt Stupfel
Chief Financial Officer
Alex Exposito
Vice President, Sales & Business Development
Mike Pierce
Vice President, Customer Success
Leadership
Ron E. Daigle
Ron has over 45 years’ experience in ultrasound research and development, including 5 years as Director of Research at ATL Ultrasound, where he developed new digital beamforming methods for high bandwidth array imaging and advanced digital Doppler color flow imaging. He then served 8 years as Director of Technology at Atlantis Diagnostics International, an ATL subsidiary charged with developing computer-based ultrasound systems. He is the author on 45 ultrasound publications and named as an inventor on 20 ultrasound patents.
Ron E. Daigle
Co-founder, Chairman & Chief Innovation Officer
Jon K. Daigle
Jon joined Verasonics in 2015. Before his appointment as President and CEO, he was responsible for strategy, commercial licensing, strategic alliances, and program management. Prior to Verasonics, Jon held various roles in corporate strategy and development, strategic marketing, and product management at Medtronic and Becton Dickinson & Co. Jon holds a BA in Business Administration from Washington State University, an MBA from Columbia Business School, and a Master of International Affairs from Columbia University’s School of International and Public Affairs.
Jon K. Daigle
President & Chief Executive Officer
Stacy Douthitt
Stacy is a senior marketing leader with 30 years of demonstrated results in commercial strategy and global marketing for medical device and life science firms. Prior to Verasonics, she held leadership positions at several MedTech companies ranging from start-up to Fortune 500. Stacy is responsible for customer success, product marketing & communications, as well as strategic marketing & alliances. She holds a B.A.in Marketing from the University of Washington, and an M.B.A. from the University of Phoenix.
.
.
Stacy Douthitt
Chief Business Officer
Matt Stupfel
Matt has over 30 years’ experience in financial, operational & commercial leadership, with an efficient record of bringing companies from early-stage start-up to publicly listed global corporations. His accomplishments include raising over $100M+ in equity and debt financing and leading corporate M&A processes, including multiple successful acquisitions. Matt is an alumnus of Seattle University
..
Matt Stupfel
Chief Financial Officer
Alex Exposito
Alex has over 25 years of experience in the ultrasound industry, having worked with multinational companies and ultrasound startups. He has held various roles in clinical, sales, and sales leadership at ATL/Philips, Fujifilm SonoSite, and Supersonic Imagine, providing best-in-class ultrasound technology to healthcare institutions prior to joining Verasonics in 2022. Alex holds a bachelor’s degree in business administration specializing in healthcare services from Barry University. Prior to his commercial healthcare experience, he worked in a clinical setting as a diagnostic medical sonographer.
Alex Exposito
Vice President, Sales & Business Development
Mike Pierce
Michael has over 25 years’ experience in ultrasound and medical device development, marketing, and field service. Prior to Verasonics, he served as Director of Marketing and Operations at Medstreaming and spent 13 years at Philips serving in a variety of positions – Connectivity Engineer, Professional Services Consultant, and Field Marketing Manager.
..
Mike Pierce
Vice President, Customer Success
